Series A - New Haven Pharmaceuticals - Oct 29, 2012 Funding Round Profile - Cointime

Bitcoin $98,536.55 +3.02%
Ethereum $3,358.55 +8.93%
BNB $635.65 +5.29%
Optimism $2.04 +23.48%
Arbitrum $0.77 +14.58%
Solana $262.27 +11.12%
Polygon $0.47 +8.31%
Cosmos $6.55 +6.01%
Avalanche $36.25 +8.98%

Bitcoin $98,536.55 +3.02%
Ethereum $3,358.55 +8.93%
BNB $635.65 +5.29%
Optimism $2.04 +23.48%
Arbitrum $0.77 +14.58%
Solana $262.27 +11.12%
Polygon $0.47 +8.31%
Cosmos $6.55 +6.01%
Avalanche $36.25 +8.98%

New Haven Pharmaceuticals

company

Funding Round

Series A

Money Raised

$ 6.49M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Advantage Capital	-	-	-	Detail
EJ Funds	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail